Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 5, 2022
[Partnership Activity for Neglected Tropical Diseases]Yuichiro Akao, Atsuko Ochida, Hiroya Muranishi, et al.Bioorganic & Medicinal Chemistry|December 25, 2021
Discovery of phenylpyrrolidine derivatives as a novel class of retinol binding protein 4 (RBP4) reducersShinji Nakamura, Masahiro Kamaura, Yuichiro Akao, et al.RSC Medicinal Chemistry|May 27, 2021
Collaborative virtual screening to elaborate an imidazo[1,2-a]pyridine hit series for visceral leishmaniasisYuichiro Akao, Stacie Canan, Yafeng Cao, et al.Journal of Medicinal Chemistry|August 26, 2021
Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious AntimalarialsBenoît Laleu, Yuichiro Akao, Atsuko Ochida, et al.Antimicrobial Agents and Chemotherapy|February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of Cryptosporidium InfectionFrederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.Ebiomedicine|March 23, 2024
High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniaeBenjamin Blasco, Soojin Jang, Hiroki Terauchi, et al.Journal of Medicinal Chemistry|January 6, 2023
Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi InfectionTaisuke Tawaraishi, Atsuko Ochida, Yuichiro Akao, et al.ACS Infectious Diseases|April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase InhibitorsMasanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.Pageof 1